INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

FIRST TRUST ADVISORS LP's Holding History (CIK: 0001125816)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 663,916 Value ($000) $87,584 Avg Close — Range —
Q4 2024
Shares 766,134 Value ($000) $63,987 Avg Close — Range —
Q3 2024
Shares 680,251 Value ($000) $49,774 Avg Close — Range —
Q2 2024
Shares 583,592 Value ($000) $39,970 Avg Close — Range —
Q1 2024
Shares 690,637 Value ($000) $47,792 Avg Close — Range —
Q4 2023
Shares 10,826 Value ($000) $775 Avg Close — Range —
Q3 2023
Shares 62,568 Value ($000) $3,259 Avg Close — Range —
Q2 2023
Shares 21,919 Value ($000) $1,388 Avg Close — Range —
Q1 2023
Shares 50,495 Value ($000) $2,734 Avg Close — Range —
Q4 2022
Shares 31,498 Value ($000) $1,667 Avg Close — Range —
Q3 2022
Shares 96,455 Value ($000) $4,488 Avg Close — Range —
Q2 2022
Shares 107,882 Value ($000) $6,158 Avg Close — Range —
Q1 2022
Shares 97,609 Value ($000) $5,973 Avg Close — Range —
Q4 2021
Shares 58,823 Value ($000) $3,079 Avg Close — Range —
Q3 2021
Shares 110,105 Value ($000) $4,105 Avg Close — Range —
Q2 2021
Shares 52,003 Value ($000) $2,123 Avg Close — Range —
Q4 2018
Shares 24,087 Value ($000) $274 Avg Close — Range —